Scarica l'app Stockscreener
71.46
0.36%
-0.26
Dopo l'orario di chiusura:
71.46
Precedente Chiudi:
$71.72
Aprire:
$70.06
Volume 24 ore:
188.44K
Relative Volume:
1.09
Capitalizzazione di mercato:
$699.39M
Reddito:
-
Utile/perdita netta:
$-14.23M
Rapporto P/E:
-36.84
EPS:
-1.9396
Flusso di cassa netto:
$-9.44M
1 W Prestazione:
-2.52%
1M Prestazione:
-13.71%
6M Prestazione:
+27.61%
1 anno Prestazione:
+102.38%
Intervallo 1D:
$68.53
$73.08
Intervallo di 1 settimana:
$66.20
$76.20
Portata 52W:
$23.18
$123.75
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Nome
Bright Minds Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare DRUG vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
71.46 | 699.39M | 0 | -14.23M | -9.44M | -1.9396 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-08 | Iniziato | BTIG Research | Buy |
| 2025-05-13 | Iniziato | TD Cowen | Buy |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-23 | Iniziato | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-26 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Responsive Playbooks and the DRUG Inflection - Stock Traders Daily
Bright Minds announces ATM offering up to $100 million - MSN
Bright Minds Biosciences Inc. (DRUG.NE) interactive stock chart - Yahoo Finance UK
Bright Minds Biosciences Inc. (DRUG.NE) Stock Forum & Discussion - Yahoo! Finance Canada
Bright Minds Biosciences Inc Live Share Prices and Trades. DRUG.US Live Streaming Share Prices. - lse.co.uk
Swing Trade: Whats the profit margin of WB PRCCLTrade Exit Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Bright Minds Biosciences (NASDAQ:DRUG) Given Buy Rating at BTIG Research - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG Research - MarketBeat
BTIG reiterates Bright Minds Biosciences stock rating on seizure treatment potential - Investing.com
What is the probability of success for Bright Minds Biosciences Inc (DRUG)’s lead drug candidate? - msn.com
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Moderate Buy” from Brokerages - defenseworld.net
Hedge Fund Bets: How much upside does Bright Minds Biosciences Inc have2026 Macro Moves & Weekly Top Stock Performers List - baoquankhu1.vn
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate? - Insider Monkey
Understanding the Setup: (DRUG) and Scalable Risk - Stock Traders Daily
Bright Minds Biosciences (DRUG) Nears Binary Phase II Data Catalyst in March 2026 - Bitget
Bright Minds Biosciences (NASDAQ:DRUG) Raised to "Hold" at Wall Street Zen - MarketBeat
Risk Off: Is PMTPRC showing insider buying2026 Decliners & Trade Opportunity Analysis Reports - baoquankhu1.vn
Pullback Watch: Is Bright Minds Biosciences Inc undervalued by DCF analysis2026 Price Momentum & Expert Approved Momentum Ideas - baoquankhu1.vn
303,685 Shares in Bright Minds Biosciences Inc. $DRUG Acquired by Braidwell LP - MarketBeat
The Technical Signals Behind (DRUG) That Institutions Follow - Stock Traders Daily
Bright Minds gains on mid-stage trial win for lead asset - MSN
Is Bright Minds Biosciences Inc. stock supported by innovation pipelineAnalyst Upgrade & Low Risk High Reward Ideas - Naître et grandir
Risk Report: Is Bright Minds Biosciences Inc a cyclical or defensive stock2025 Retail Activity & Daily Volume Surge Signals - baoquankhu1.vn
Bright Minds Biosciences sets January 6 webcast for BMB-101 phase 2 topline results in drug-resistant absence seizures - MSN
Market Outlook: What is the Moat Score of Bright Minds Biosciences IncJuly 2025 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
HC Wainwright Has Bullish Forecast for DRUG Q2 Earnings - MarketBeat
HC Wainwright Raises Bright Minds Biosciences (NASDAQ:DRUG) Price Target to $145.00 - Defense World
Bright Minds stock price target raised to $145 by H.C. Wainwright on trial data - Investing.com
Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
DRUG: HC Wainwright & Co. Raises Price Target to $145, Maintains Buy Rating | DRUG Stock News - GuruFocus
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Precision Trading with Bright Minds Biosciences Inc. (DRUG) Risk Zones - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
DRUG Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bright Minds Biosciences to Present at Upcoming Conferences - The Manila Times
Published on: 2026-02-24 23:01:51 - baoquankhu1.vn
Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap UpWhat's Next? - MarketBeat
Stock Report: What are Bright Minds Biosciences Incs recent SEC filings showingJuly 2025 Chart Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Baird lowers Bright Minds Biosciences Inc. (DRUG) price target to $126, maintains outperform rating ahead of upcoming trials - MSN
Technical Reactions to DRUG Trends in Macro Strategies - Stock Traders Daily
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials - Finviz
Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 7.9%Here's What Happened - MarketBeat
Will Bright Minds Biosciences Inc. benefit from rate cutsWeekly Trading Summary & AI Based Trade Execution Alerts - mfd.ru
Commodore Capital updates DRUG stake to 0.3% in Schedule 13G/A filing - Stock Titan
7 Most Promising Psychedelic Stocks According to Hedge Funds - Insider Monkey
What are Bright Minds Biosciences Inc.’s recent SEC filings showingRate Cut & Weekly Top Gainers Trade List - mfd.ru
Wall Street Zen Upgrades Bright Minds Biosciences (NASDAQ:DRUG) to Hold - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Down 6.2%Time to Sell? - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Issues Earnings Results, Beats Estimates By $0.28 EPS - MarketBeat
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss - TipRanks
Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):